Medpace Holdings Statistics
Total Valuation
MEDP has a market cap or net worth of $10.53 billion. The enterprise value is $10.11 billion.
| Market Cap | 10.53B |
| Enterprise Value | 10.11B |
Important Dates
The last earnings date was Monday, October 21, 2024, after market close.
| Earnings Date | Oct 21, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MEDP has 31.01 million shares outstanding. The number of shares has increased by 0.09% in one year.
| Current Share Class | 31.01M |
| Shares Outstanding | 31.01M |
| Shares Change (YoY) | +0.09% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 17.81% |
| Owned by Institutions (%) | 83.77% |
| Float | 25.47M |
Valuation Ratios
The trailing PE ratio is 29.80 and the forward PE ratio is 27.94. MEDP's PEG ratio is 1.85.
| PE Ratio | 29.80 |
| Forward PE | 27.94 |
| PS Ratio | 5.11 |
| Forward PS | 4.73 |
| PB Ratio | 12.05 |
| P/TBV Ratio | 57.05 |
| P/FCF Ratio | 19.63 |
| P/OCF Ratio | 18.30 |
| PEG Ratio | 1.85 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.11, with an EV/FCF ratio of 18.88.
| EV / Earnings | 27.66 |
| EV / Sales | 4.88 |
| EV / EBITDA | 23.11 |
| EV / EBIT | 24.74 |
| EV / FCF | 18.88 |
Financial Position
The company has a current ratio of 0.99, with a Debt / Equity ratio of 0.17.
| Current Ratio | 0.99 |
| Quick Ratio | 0.93 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 0.32 |
| Debt / FCF | 0.28 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 54.08% and return on invested capital (ROIC) is 30.64%.
| Return on Equity (ROE) | 54.08% |
| Return on Assets (ROA) | 14.31% |
| Return on Capital (ROIC) | 30.64% |
| Revenue Per Employee | $350,994 |
| Profits Per Employee | $61,961 |
| Employee Count | 5,900 |
| Asset Turnover | 1.16 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MEDP has paid $67.08 million in taxes.
| Income Tax | 67.08M |
| Effective Tax Rate | 15.50% |
Stock Price Statistics
The stock price has increased by +23.17% in the last 52 weeks. The beta is 1.36, so MEDP's price volatility has been higher than the market average.
| Beta (5Y) | 1.36 |
| 52-Week Price Change | +23.17% |
| 50-Day Moving Average | 337.43 |
| 200-Day Moving Average | 378.54 |
| Relative Strength Index (RSI) | 50.97 |
| Average Volume (20 Days) | 371,678 |
Short Selling Information
The latest short interest is 1.14 million, so 3.67% of the outstanding shares have been sold short.
| Short Interest | 1.14M |
| Short Previous Month | 1.10M |
| Short % of Shares Out | 3.67% |
| Short % of Float | 4.46% |
| Short Ratio (days to cover) | 2.71 |
Income Statement
In the last 12 months, MEDP had revenue of $2.07 billion and earned $365.57 million in profits. Earnings per share was $11.42.
| Revenue | 2.07B |
| Gross Profit | 1.39B |
| Operating Income | 408.81M |
| Pretax Income | 397.17M |
| Net Income | 365.57M |
| EBITDA | 437.53M |
| EBIT | 408.81M |
| Earnings Per Share (EPS) | $11.42 |
Balance Sheet
The company has $656.90 million in cash and $151.89 million in debt, giving a net cash position of $505.01 million or $16.28 per share.
| Cash & Cash Equivalents | 656.90M |
| Total Debt | 151.89M |
| Net Cash | 505.01M |
| Net Cash Per Share | $16.28 |
| Equity (Book Value) | 881.44M |
| Book Value Per Share | 28.42 |
| Working Capital | -8.76M |
Cash Flow
In the last 12 months, operating cash flow was $574.54 million and capital expenditures -$38.89 million, giving a free cash flow of $535.65 million.
| Operating Cash Flow | 574.54M |
| Capital Expenditures | -38.89M |
| Free Cash Flow | 535.65M |
| FCF Per Share | $17.27 |
Margins
Gross margin is 67.22%, with operating and profit margins of 19.74% and 17.66%.
| Gross Margin | 67.22% |
| Operating Margin | 19.74% |
| Pretax Margin | 20.90% |
| Profit Margin | 17.66% |
| EBITDA Margin | 21.13% |
| EBIT Margin | 19.74% |
| FCF Margin | 24.77% |
Dividends & Yields
MEDP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.09% |
| Shareholder Yield | -0.09% |
| Earnings Yield | 3.48% |
| FCF Yield | 5.09% |
Analyst Forecast
The average price target for MEDP is $389.00, which is 14.57% higher than the current price. The consensus rating is "Buy".
| Price Target | $389.00 |
| Price Target Difference | 14.57% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 13.65% |
| EPS Growth Forecast (5Y) | 16.54% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MEDP has an Altman Z-Score of 7.05 and a Piotroski F-Score of 6.
| Altman Z-Score | 7.05 |
| Piotroski F-Score | 6 |